Full Year 2019 Integral Diagnostics Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Integral Diagnostics, IDX, FY '19 Results Conference Call. (Operator Instructions)
I would now like to hand the conference over to Mr. Ian Kadish, CEO and Managing Director. Please go ahead.
Thank you very much. Our presentation today will be in 2 parts. We'll be presenting on the results for financial year '19, and then we will present on the acquisition and entitlement offer in a little more detail.
I'm pleased to report another strong year of growth and profit for Integral Diagnostics in financial year '19. We delivered solid growth in financial year '19, a 41% growth in our bottom line operating net profit after-tax, 40% growth -- 39% growth in operating EBITDA, 30% growth in operating earnings per share, 23% growth in operating revenue and a 39% growth in our statutory net profit after-tax. We successfully integrated significant acquisitions in Auckland and in Geelong, and both of those acquisitions are performing in line with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |